I think it is safe to say nothing that doesn't start with a $ sign, and I can't imagine BOT management being prepared to let it go for anything less than $2.50 - and that is just based on SB alone, not taking into account any of the pipeline. With the potential for antimicrobial, rosacea and acne sitting there in the wings, I just can't imagine BOT being prepared to sell the company for any less than $5. It'll be worth that and then some in a few short years.
BOT - Anything but charting, page-6776
-
- There are more pages in this discussion • 2,620 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.025(7.04%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 38.0¢ | 36.0¢ | $3.158M | 8.589M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 141840 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 135173 | 2 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |